Current approaches to the management of brain metastases

JH Suh, R Kotecha, ST Chao, MS Ahluwalia… - Nature reviews Clinical …, 2020 - nature.com
Brain metastases are a very common manifestation of cancer that have historically been
approached as a single disease entity given the uniform association with poor clinical …

Response assessment criteria for brain metastases: proposal from the RANO group

NU Lin, EQ Lee, H Aoyama, IJ Barani… - The lancet …, 2015 - thelancet.com
CNS metastases are the most common cause of malignant brain tumours in adults.
Historically, patients with brain metastases have been excluded from most clinical trials, but …

Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases

TJ Kaufmann, M Smits, J Boxerman, R Huang… - Neuro …, 2020 - academic.oup.com
A recent meeting was held on March 22, 2019, among the FDA, clinical scientists,
pharmaceutical and biotech companies, clinical trials cooperative groups, and patient …

[HTML][HTML] Diagnosis and management of radiation necrosis in patients with brain metastases

B Vellayappan, CL Tan, C Yong, LK Khor… - Frontiers in …, 2018 - frontiersin.org
The use of radiotherapy, either in the form of stereotactic radiosurgery (SRS) or whole-brain
radiotherapy (WBRT), remains the cornerstone for the treatment of brain metastases (BM) …

Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?

RJ Colaco, P Martin, HM Kluger, BY James… - Journal of …, 2016 - thejns.org
OBJECT Radiation necrosis (RN), or its imaging equivalent, treatment-related imaging
changes (TRIC), is an inflammatory reaction to high-dose radiation in the brain. The authors …

Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery

JM Qian, JB Yu, HM Kluger, VLS Chiang - Cancer, 2016 - Wiley Online Library
BACKGROUND Growing evidence suggests that immunotherapy and radiation therapy can
be synergistic in the treatment of cancer. This study was performed to determine the effect of …

Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression

N Galldiks, M Kocher, G Ceccon, JM Werner… - Neuro …, 2020 - academic.oup.com
The advent of immunotherapy using immune checkpoint inhibitors (ICIs) and targeted
therapy (TT) has dramatically improved the prognosis of various cancer types. However …

Brain metastases: neuroimaging

WB Pope - Handbook of clinical neurology, 2018 - Elsevier
Magnetic resonance imaging (MRI) is the cornerstone for evaluating patients with brain
masses such as primary and metastatic tumors. Important challenges in effectively detecting …

[PDF][PDF] Stereotactic radiosurgery for treatment of brain metastases

M Kocher, A Wittig, MD Piroth… - strahlentherapie und …, 2014 - 57357.org
However, the number of randomized clinical trials performed to evaluate the therapeutic
options for brain metastases is still limited, leaving evidence-based management of this …

Distinguishing true progression from radionecrosis after stereotactic radiation therapy for brain metastases with machine learning and radiomics

L Peng, V Parekh, P Huang, DD Lin, K Sheikh… - International Journal of …, 2018 - Elsevier
Purpose Treatment effect or radiation necrosis after stereotactic radiosurgery (SRS) for brain
metastases is a common phenomenon often indistinguishable from true progression …